ArticlePragmatic and observational research2026

The Potential Impact of GLP-1 Receptor Agonists on Exacerbation Risk in Patients with COPD and Type 2 Diabetes: A Real-World Population-Based Observational Study.

Bernardino Alcázar-Navarrete et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.